The Kidney and Hypertension in Diabetes Mellitus

1. Pressure induced and metabolic alterations in the glomerulus: Role in cytokine activity and progressive sclerosis.- 2. Definition of diabetic renal disease in insulin-dependent diabetes mellitus based on renal function tests.- 3. Retinopathy in relation to albuminuria and blood pressure in IDDM.- 4. Microalbuminuria and cardiovascular disease.- 5. The heart in diabetes: results of trials.- 6. Albuminuria in non-insulin-dependent diabetes — renal or “extra” renal disease?.- 7. The clinical course of renal disease in Caucasian NIDDM-patients.- 8. Serum creatinine and other measures of GFR in diabetes.- 9. Familial factors in diabetic nephropathy.- 10. Genetics and diabetic nephropathy.- 11. Birth, Barker and Brenner: The concept of low birth weight and renal disease.- 12. Effect of insulin on the kidney and the cardiovascular system.- 13 Value of screening for microalbuminuria in people with diabetes as well as in the general population.- 14. Incidence of nephropathy in IDDM as related to mortality. Cost and benefits of early intervention..- 15. Dysfunction of the vascular endothelium and the development of renal and vascular complications in diabetes.- 16. Urinary tract infections in patients with diabetes mellitus.- 17. Light microscopy of diabetic glomerulopathy: the classic lesions.- 18. Renal structural changes in patients with type 1 diabetes and microalbuminuria.- 19. Renal structure in type 2 diabetic patients with microalbuminuria.- 20. Nephropathy in NIDDM patients, predictors of outcome.- 21. Advanced glycation end-products and diabetic renal disease.- 22. Protein kinase C in diabetic renal involvement, the perspective of inhibition.- 23. Biochemical aspects of diabetic nephropathy.- 24. Pathogenesis of diabetic glomerulopathy: the role of glomerularhemodynamic factors.- 25. An update on the role of growth factors in the development of diabetic kidney disease.- 26. Transforming growth factor-? and other cytokines in experimental and human diabetic nephropathy.- 27. Blood pressure elevation in diabetes: the results from 24-h ambulatory blood pressure recordings.- 28. Microalbuminuria in young patients with type 1 diabetes.- 29. Early renal hyperfunction and hypertrophy in IDDM patients including comments on early intervention.- 30. Diabetes, hypertension, and kidney disease in the Pima Indians.- 31. Autoregulation of glomerular filtration rate in patients with diabetes.- 32. ACE-inhibition, angiotensin II receptor blockade, and diabetic nephropathy.- 33. The concept of incipient diabetic nephropathy and effect of early antihypertensive intervention.- 34. Reversibility of diabetic nephropathy lesions: A new concept.- 35. Antihypertensive treatment in NIDDM, with special reference to abnormal albuminuria..- 36. The course of incipient and overt diabetic nephropathy: the perspective of more optimal treatment, including UKPDS-perspective.- 37. Non-glycaemic intervention in diabetic nephropathy: the role of dietary protein intake.- 38. Diabetic nephropathy and pregnancy.- 39. Evolution worldwide of renal replacement therapy in diabetes.- 40. Haemodialysis and CAPD in type 1 and type 2 diabetic patients with endstage renal failure.- 41. Renal transplantation for diabetic nephropathy.- 42. Combination therapy for hypertension and renal disease in diabetes.- 43. Microalbuminuria in essential hypertension. Significance for the cardiovascular and renal systems.- 44. A comparison of progression in diabetic and non-diabetic renal disease: similarity of progression promoters.- 45. Update of the latest intervention trials inhypertension and type 2 diabetes.- 46. Scientific basis for the new guidelines for the treatment of hypertension in type 2 diabetes.- 47. Regulatory considerations in the development of therapies for diabetic nephropathy and related conditions.- 48. The renin angiotensin system in the pathogenesis of diabetic complications.- 49. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas.